<DOC>
	<DOCNO>NCT00324038</DOCNO>
	<brief_summary>The primary objective compare buprenorphine transdermal delivery system ( BTDS ) standard- treatment subject osteoarthritis ( OA ) .</brief_summary>
	<brief_title>Buprenorphine Treatment Osteoarthritis ( OA ) Elderly</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Codeine</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Either sex age 65 Diagnosis OA hip and/or knee Severe pain require step two medication Taking maximum dose paracetamol Painful disease joint OA Contraindication buprenorphine , opioids , patch adhesive nonsteroidal antiinflammatory agent ( NSAIDS ) Subjects take cyclooxygenase ( COX ) II selective inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>OA</keyword>
	<keyword>Elderly</keyword>
	<keyword>Pain</keyword>
	<keyword>OA hip and/or knee</keyword>
</DOC>